GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kali Inc (OTCPK:KALY) » Definitions » EV-to-EBIT
中文

Kali (KALY) EV-to-EBIT

: 0.00 (As of Today)
View and export this data going back to 2008. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Kali's Enterprise Value is $0.0 Mil. Kali's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 was $27.8 Mil. Therefore, Kali's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Kali's EV-to-EBIT or its related term are showing as below:

KALY's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.02
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Kali's Enterprise Value for the quarter that ended in Mar. 2013 was $-19.9 Mil. Kali's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 was $27.8 Mil. Kali's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2013 was -139.91%.


Kali EV-to-EBIT Historical Data

The historical data trend for Kali's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kali Annual Data
Trend Nov06 Nov07 Nov08 Dec09 Dec10 Dec11 Dec12
EV-to-EBIT
Get a 7-Day Free Trial -2,790.38 4.28 1.56 1.38 -0.73

Kali Quarterly Data
May08 Aug08 Nov08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 -0.24 0.08 -0.73 -0.73

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kali's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kali EV-to-EBIT Distribution

For the Drug Manufacturers industry and Healthcare sector, Kali's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kali's EV-to-EBIT falls into.



Kali EV-to-EBIT Calculation

Kali's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/27.801
=0.00

Kali's current Enterprise Value is $0.0 Mil.
Kali's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kali  (OTCPK:KALY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Kali's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2013 ) =EBIT / Enterprise Value (Q: Mar. 2013 )
=27.801/-19.8702888
=-139.91 %

Kali's Enterprise Value for the quarter that ended in Mar. 2013 was $-19.9 Mil.
Kali's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kali EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Kali's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Kali (KALY) Business Description

Traded in Other Exchanges
N/A
Address
8300 Douglas Avenue, Suite 800, Dallas, TX, USA, 75225
Kali Inc is a United States based company involved in cannabis extraction business. It focuses on development of pharmaceuticals to treat various illnesses, diseases and chronic pain as a symptom of various diagnoses. The company also concentrates on the development of health and wellness therapies.
Executives
Tchaikovsky Bennet Price Jr officer: Chief Financial Officer 11601 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90025
Ying Teresa Zhang director NO. 9 YANYU MIDDLE ROAD, QIANZHOU VILLAGE, HUISHAN DISTRICT, WUXI JIANGSU F4 214181
Bradley W Miller director, 10 percent owner, officer: CEO BLOCK C FLAT 410, LOTUS HILL GOLF APTS., LOTUS HILL TOWN, PANYU DISTRICT, GUANGZHOU F4 511440